LPL Financial’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $345K | Buy |
38,939
+3,277
| +9% | +$29K | ﹤0.01% | 4579 |
|
|
2025
Q1 | $279K | Buy |
35,662
+1,537
| +5% | +$12K | ﹤0.01% | 4523 |
|
|
2024
Q4 | $359K | Buy |
34,125
+10,072
| +42% | +$106K | ﹤0.01% | 4281 |
|
|
2024
Q3 | $315K | Sell |
24,053
-519
| -2% | -$6.81K | ﹤0.01% | 4302 |
|
|
2024
Q2 | $345K | Sell |
24,572
-1,175
| -5% | -$16.5K | ﹤0.01% | 4087 |
|
|
2024
Q1 | $435K | Buy |
25,747
+2,190
| +9% | +$37K | ﹤0.01% | 3843 |
|
|
2023
Q4 | $333K | Buy |
23,557
+3,427
| +17% | +$48.4K | ﹤0.01% | 3957 |
|
|
2023
Q3 | $207K | Sell |
20,130
-278
| -1% | -$2.86K | ﹤0.01% | 4154 |
|
|
2023
Q2 | $336K | Buy |
20,408
+4,958
| +32% | +$81.7K | ﹤0.01% | 3711 |
|
|
2023
Q1 | $142K | Sell |
15,450
-13,000
| -46% | -$119K | ﹤0.01% | 4108 |
|
|
2022
Q4 | $204K | Hold |
28,450
| – | – | ﹤0.01% | 3947 |
|
|
2022
Q3 | $143K | Sell |
28,450
-2,400
| -8% | -$12.1K | ﹤0.01% | 3997 |
|
|
2022
Q2 | $75K | Buy |
30,850
+8,900
| +41% | +$21.6K | ﹤0.01% | 4150 |
|
|
2022
Q1 | $150K | Buy |
21,950
+2,400
| +12% | +$16.4K | ﹤0.01% | 3883 |
|
|
2021
Q4 | $158K | Buy |
19,550
+600
| +3% | +$4.85K | ﹤0.01% | 4028 |
|
|
2021
Q3 | $186K | Sell |
18,950
-200
| -1% | -$1.96K | ﹤0.01% | 3982 |
|
|
2021
Q2 | $129K | Buy |
19,150
+3,000
| +19% | +$20.2K | ﹤0.01% | 3987 |
|
|
2021
Q1 | $146K | Buy |
16,150
+5,900
| +58% | +$53.3K | ﹤0.01% | 3831 |
|
|
2020
Q4 | $68K | Sell |
10,250
-800
| -7% | -$5.31K | ﹤0.01% | 3696 |
|
|
2020
Q3 | $56K | Sell |
11,050
-2,133
| -16% | -$10.8K | ﹤0.01% | 3406 |
|
|
2020
Q2 | $107K | Buy |
+13,183
| New | +$107K | ﹤0.01% | 3254 |
|